143 related articles for article (PubMed ID: 24664761)
1. Episomal maintenance of S/MAR-containing non-viral vectors for RPE-based diseases.
Koirala A; Conley SM; Naash MI
Adv Exp Med Biol; 2014; 801():703-9. PubMed ID: 24664761
[TBL] [Abstract][Full Text] [Related]
2. S/MAR-containing DNA nanoparticles promote persistent RPE gene expression and improvement in RPE65-associated LCA.
Koirala A; Makkia RS; Conley SM; Cooper MJ; Naash MI
Hum Mol Genet; 2013 Apr; 22(8):1632-42. PubMed ID: 23335596
[TBL] [Abstract][Full Text] [Related]
3. MAR characteristic motifs mediate episomal vector in CHO cells.
Lin Y; Li Z; Wang T; Wang X; Wang L; Dong W; Jing C; Yang X
Gene; 2015 Apr; 559(2):137-43. PubMed ID: 25598284
[TBL] [Abstract][Full Text] [Related]
4. Persistence of non-viral vector mediated RPE65 expression: case for viability as a gene transfer therapy for RPE-based diseases.
Koirala A; Conley SM; Makkia R; Liu Z; Cooper MJ; Sparrow JR; Naash MI
J Control Release; 2013 Dec; 172(3):745-52. PubMed ID: 24035979
[TBL] [Abstract][Full Text] [Related]
5. Non-integrating lentiviral vectors based on the minimal S/MAR sequence retain transgene expression in dividing cells.
Xu Z; Chen F; Zhang L; Lu J; Xu P; Liu G; Xie X; Mu W; Wang Y; Liu D
Sci China Life Sci; 2016 Oct; 59(10):1024-1033. PubMed ID: 27614752
[TBL] [Abstract][Full Text] [Related]
6. Persistent episomal transgene expression in liver following delivery of a scaffold/matrix attachment region containing non-viral vector.
Argyros O; Wong SP; Niceta M; Waddington SN; Howe SJ; Coutelle C; Miller AD; Harbottle RP
Gene Ther; 2008 Dec; 15(24):1593-605. PubMed ID: 18633447
[TBL] [Abstract][Full Text] [Related]
7. The functional role of S/MARs in episomal vectors as defined by the stress-induced destabilization profile of the vector sequences.
Giannakopoulos A; Stavrou EF; Zarkadis I; Zoumbos N; Thrasher AJ; Athanassiadou A
J Mol Biol; 2009 Apr; 387(5):1239-49. PubMed ID: 19248788
[TBL] [Abstract][Full Text] [Related]
8. Efficient episomal gene transfer to human hepatic cells using the pFAR4-S/MAR vector.
Giannakopoulos A; Quiviger M; Stavrou E; Verras M; Marie C; Scherman D; Athanassiadou A
Mol Biol Rep; 2019 Jun; 46(3):3203-3211. PubMed ID: 30980265
[TBL] [Abstract][Full Text] [Related]
9. Advances in the Development and the Applications of Nonviral, Episomal Vectors for Gene Therapy.
Mulia GE; Picanço-Castro V; Stavrou EF; Athanassiadou A; Figueiredo ML
Hum Gene Ther; 2021 Oct; 32(19-20):1076-1095. PubMed ID: 34348480
[TBL] [Abstract][Full Text] [Related]
10. Gene transfer into human hematopoietic progenitor cells with an episomal vector carrying an S/MAR element.
Papapetrou EP; Ziros PG; Micheva ID; Zoumbos NC; Athanassiadou A
Gene Ther; 2006 Jan; 13(1):40-51. PubMed ID: 16094410
[TBL] [Abstract][Full Text] [Related]
11. Generation of a tumor- and tissue-specific episomal non-viral vector system.
Haase R; Magnusson T; Su B; Kopp F; Wagner E; Lipps H; Baiker A; Ogris M
BMC Biotechnol; 2013 Jun; 13():49. PubMed ID: 23734827
[TBL] [Abstract][Full Text] [Related]
12. Non-viral episomal modification of cells using S/MAR elements.
Argyros O; Wong SP; Harbottle RP
Expert Opin Biol Ther; 2011 Sep; 11(9):1177-91. PubMed ID: 21548848
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy following subretinal AAV5 vector delivery is not affected by a previous intravitreal AAV5 vector administration in the partner eye.
Li W; Kong F; Li X; Dai X; Liu X; Zheng Q; Wu R; Zhou X; Lü F; Chang B; Li Q; Hauswirth WW; Qu J; Pang JJ
Mol Vis; 2009; 15():267-75. PubMed ID: 19190735
[TBL] [Abstract][Full Text] [Related]
14. Non-viral S/MAR vectors replicate episomally in vivo when provided with a selective advantage.
Wong SP; Argyros O; Coutelle C; Harbottle RP
Gene Ther; 2011 Jan; 18(1):82-7. PubMed ID: 20739959
[TBL] [Abstract][Full Text] [Related]
15. Physiological levels of HBB transgene expression from S/MAR element-based replicating episomal vectors.
Sgourou A; Routledge S; Spathas D; Athanassiadou A; Antoniou MN
J Biotechnol; 2009 Aug; 143(2):85-94. PubMed ID: 19559736
[TBL] [Abstract][Full Text] [Related]
16. The Status of RPE65 Gene Therapy Trials: Safety and Efficacy.
Pierce EA; Bennett J
Cold Spring Harb Perspect Med; 2015 Jan; 5(9):a017285. PubMed ID: 25635059
[TBL] [Abstract][Full Text] [Related]
17. Assembly and Functional Analysis of an S/MAR Based Episome with the Cystic Fibrosis Transmembrane Conductance Regulator Gene.
De Rocco D; Pompili B; Castellani S; Morini E; Cavinato L; Cimino G; Mariggiò MA; Guarnieri S; Conese M; Del Porto P; Ascenzioni F
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29673202
[TBL] [Abstract][Full Text] [Related]
18. Shortened nuclear matrix attachment regions are sufficient for replication and maintenance of episomes in mammalian cells.
Wang XY; Zhang X; Wang TY; Jia YL; Xu DH; Yi DD
Mol Biol Cell; 2019 Oct; 30(22):2761-2770. PubMed ID: 31509492
[TBL] [Abstract][Full Text] [Related]
19. Retinal pigmented epithelial cells obtained from human induced pluripotent stem cells possess functional visual cycle enzymes in vitro and in vivo.
Maeda T; Lee MJ; Palczewska G; Marsili S; Tesar PJ; Palczewski K; Takahashi M; Maeda A
J Biol Chem; 2013 Nov; 288(48):34484-93. PubMed ID: 24129572
[TBL] [Abstract][Full Text] [Related]
20. An S/MAR-based infectious episomal genomic DNA expression vector provides long-term regulated functional complementation of LDLR deficiency.
Lufino MM; Manservigi R; Wade-Martins R
Nucleic Acids Res; 2007; 35(15):e98. PubMed ID: 17675302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
